Your session is about to expire
← Back to Search
High-Risk Screening for Lung Cancer
N/A
Waitlist Available
Led By Melissa New, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of the study, up to 3 years
Awards & highlights
Summary
This trial is testing a new screening method for people who are at high risk for lung cancer, but don't qualify for current screening guidelines.
Eligible Conditions
- Lung Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ duration of the study, up to 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of the study, up to 3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Economic Outcomes
Lung Cancer Screening
Medical Outcomes
Trial Design
1Treatment groups
Experimental Treatment
Group I: ScreeningExperimental Treatment1 Intervention
Subjects will undergo a low dose non contrast CT chest for lung cancer screening.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Screening
2005
N/A
~55440
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,758 Previous Clinical Trials
2,166,212 Total Patients Enrolled
Melissa New, MDPrincipal InvestigatorUniversity of Colorado, Denver
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are not able or do not want to receive treatment for lung cancer.You are between 55 and 80 years old, have smoked the equivalent of 30 pack-years, and are either still smoking or quit within the last 15 years.You had a chest CT scan within the past year.You are between 40 and 82 years old.You are expected to live for less than 6 months.You have symptoms that are similar to those of lung cancer.Your calculated risk of developing lung cancer in the next 6 years is higher than a certain percentage for your age group.
Research Study Groups:
This trial has the following groups:- Group 1: Screening
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger